British Journal of Urology · 2019 · 25 citations · 22 references
MedicineOncologySurgeryOncologic SurgerySurgical OncologySurvival AnalysisCancer Survival AnalysisPenile CancerPenile SurgeryPrognostic AssessmentSquamous Cell CarcinomaCox RegressionInguinal Lymph Node DissectionInguinal Lymph Node ManagementLymph Node YieldOperating Characteristic CurvesPenile Cancer PrognosisPrognostic PredictionPrognostic Variables
OBJECTIVE: To evaluate the prognostic impact of lymph node yield (LNY) on survival outcomes for penile squamous cell carcinoma (SCC). PATIENTS AND METHODS: In all, 532 patients who underwent inguinal LN dissection (ILND) across tertiary referral centres from Europe, China, Brazil and North America were retrospectively evaluated. From this cohort, 198 patients received pelvic LND (PLND).We identified threshold values for ILND and PLND using receiver operating characteristic curves. We tested prognostic value of LNY for recurrence-free survival (RFS), disease-specific survival (DSS), and overall survival (OS) using the Kaplan-Meir method and Cox proportional hazard regression models. RESULTS: The median (interquartile [IQR]) age was 59 (49-68) years and the median (IQR) follow-up after ILND was 28 (12-68.2) months. Overall, 85% of the patients had bilateral dissections. The median (IQR) number of inguinal LNs removed was 15 (10-22). Of those receiving PLND, The median (IQR) number of LNs was 13 (8-19). A LNY of ≥15 was used for dichotomisation of ILND patients, and a LNY of ≥9 was used in the PLND cohort. Patients with a LNY ≥15 had significantly better 5-year OS vs patients with a LNY <15 (70.1% vs 58.7%). On multivariable analyses, a LNY ≥15 was a predictor of OS (hazard ratio [HR] 0.68, P = 0.029). For cN0 patients, a LNY ≥15 was an independent predictor of RFS (HR 0.52, P = 0.043) and OS (HR 0.53, P = 0.021). In the PLND cohort, a LNY ≥9 was a predictor of RFS (HR 0.53, P = 0.032). CONCLUSIONS: Using one of the largest LND datasets to date, we found LNY to be a significant predictor of outcomes after lymphatic staging for penile SCC. Prospective validation is warranted.
22
EAU Guidelines on Penile Cancer: 2014 Update
Oliver W. Hakenberg, Éva Compérat, Suks Minhas et al. · European Urology · 2014 · 595 citations
EAU Penile Cancer Guidelines 2009
Giorgio Pizzocaro, Ferrán Algaba, Simon Horenblas et al. · European Urology · 2010 · 386 citations
Penile Cancer: Relation of Extent of Nodal Metastasis to Survival
V. Srinivas, Michael J. Morse, H.W. Herr et al. · The Journal of Urology · 1987 · 274 citations